Zpráva o průběhu klinického hodnocení MEMMAT 28. listopad 2022 - 26. květen 2023
| Title in English | MEMMAT Clinical Trial Progress Report November 28, 2022 - May 26, 2023 |
|---|---|
| Authors | |
| Year of publication | 2023 |
| MU Faculty or unit | |
| Web | MEMMAT |
| Description | The aim of the study is to extend therapy options for children with recurrent or progressive medulloblastoma, ependymoma and atypical teratoid rhabdoid tumor (ATRT), for whom no known curative therapy exists, by prolonging survival while maintaining good quality of life. Semi-Annual reports on the progress of clinical trials describe the course of clinical trial in the observed period of time. The reports include information on screening, enrollment (number of newly enrolled patients, general overview of patients enrolled so far, number of prematurely discontinued patients), incidence of serious adverse events, identified protocol violations, information on newly identified characteristics on investigational medicinal product in relation to safety and efficacy, newly adopted measures (eg interventions of ethics committees, foreign control authorities, possible restrictive interventions of the contracting authority) and information on performed internal audits or audits by the contracting authority if applicable. |